- Home
- TALK vs PSNL Comparison
TALK vs PSNL Comparison
Compare TALK & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALK
- PSNL
- Stock Information
- Founded
- TALK 2012
- PSNL 2011
- Country
- TALK United States
- PSNL United States
- Employees
- TALK N/A
- PSNL N/A
- Industry
- TALK Medical/Nursing Services
- PSNL Medical Specialities
- Sector
- TALK Health Care
- PSNL Health Care
- Exchange
- TALK Nasdaq
- PSNL Nasdaq
- Market Cap
- TALK 435.4M
- PSNL 484.0M
- IPO Year
- TALK N/A
- PSNL 2019
- Fundamental
- Price
- TALK $2.80
- PSNL $4.83
- Analyst Decision
- TALK Buy
- PSNL Strong Buy
- Analyst Count
- TALK 6
- PSNL 4
- Target Price
- TALK $4.50
- PSNL $8.13
- AVG Volume (30 Days)
- TALK 1.6M
- PSNL 1.1M
- Earning Date
- TALK 08-05-2025
- PSNL 08-05-2025
- Dividend Yield
- TALK N/A
- PSNL N/A
- EPS Growth
- TALK N/A
- PSNL N/A
- EPS
- TALK 0.02
- PSNL N/A
- Revenue
- TALK $202,611,000.00
- PSNL $80,317,000.00
- Revenue This Year
- TALK $21.98
- PSNL $0.45
- Revenue Next Year
- TALK $20.60
- PSNL $25.75
- P/E Ratio
- TALK $165.52
- PSNL N/A
- Revenue Growth
- TALK 17.43
- PSNL 0.36
- 52 Week Low
- TALK $1.70
- PSNL $2.83
- 52 Week High
- TALK $4.36
- PSNL $7.79
- Technical
- Relative Strength Index (RSI)
- TALK 63.99
- PSNL 42.97
- Support Level
- TALK $2.53
- PSNL $4.44
- Resistance Level
- TALK $2.53
- PSNL $4.88
- Average True Range (ATR)
- TALK 0.12
- PSNL 0.30
- MACD
- TALK 0.04
- PSNL 0.02
- Stochastic Oscillator
- TALK 95.87
- PSNL 49.25
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.